Medical Science Liaison Manager (m/f/d), MS, Leipzig, Dresden, Erfurt, Frankfurt/Oder

Req #: 1901678
Location: Offsite, Germany
Job Category: Clinical Development
Work Location: OFFSITE
Organization: MSL/RML
Employee Status: Full-time
Job Type: Regular

The Regional Medical Liaison (RML) is a member of a field-based team of scientists who function as an extension of the EMEA Medical Affairs organization. RMLs are responsible for developing and enhancing professional relationships with medical thought leaders involved in various phases of product development. RMLs provide medical information through scientific exchange in a fair-balanced manner and provide clinical/scientific support for Celgene and the EMEA Medical Affairs department. The emphasis of this position is the close collaboration with MS experts, Clinical R&D, CROs and medical affairs functions to ensure that Celgene becomes a partner to the Neurology community. As appropriate the RML will have responsibility to provide insights and education to HCPs on Celgene products and the medical value they deliver.
This is a field-based position and requires professionals with established credibility to interact with thought leaders and centers of excellence. The position involves travel of more than 50%.

Responsibilities will also include, but are not limited to, the following:

• Identify, develop and maintain collaborative relationships with current and future Key Opinion Leaders (KOLs) and healthcare stakeholders in disease states of strategic importance to Celgene.
• Provide clinical presentations and information in response to unsolicited questions (as appropriate) in academic, community and healthcare provider setting in both group and one-on- one settings.
• Collaborate with the Clinical organization to enhance patient enrolment in Celgene-sponsored clinical trials by identifying appropriate trial sites and interacting with investigators in ongoing studies (as required).
• Act as a primary liaison to investigators interested in developing and performing investigator initiated research.
• Develop and execute territory plans in alignment with regional and national plans of action (POAs).
• Assist in the reconnaissance of Market landscape determination and competitive intelligence including therapeutic trends and unmet needs within the appropriate disease states and marketplace and provide timely feedback/information on emerging clinical/scientific. information and opportunities to internal stakeholders.
• Good understanding of in-country market access environment.
• Provide scientific support at medical congresses.

Skills/Knowledge Required:

• Strong identification with Celgene's values.
• Completed Bachelor's degree.
• Extensive experience in Medical Affairs and/or drug development supporting specialty care compounds/products.
• Clinical/protocol experience needed.
• Current working knowledge of local (several countries or territory), legal, regulatory, and compliance regulations and guidelines relevant to industry interactions with health-care professionals.
• Ability to effectively partner and maintain relationships within the medical community.
• Ability to work cross functionally especially with market access and commercial teams.
• Effective communication at all times. Experience in delivering complex messages to various internal and external customers with a track record of effective and impactful presentations.
• Superior interpersonal and organizational skills with high emotional intelligence. Excellent listener; inclusive, seeks broad input and feedback; frequent and effective feedback/follow-up.
• Ability to work effectively in complex, rapidly changing environments.
• Overnight business travel of more than 50% is required.

Preferred Skills/Experience:

• Completed MD, DO, PharmD, MSN, PhD or MS in a scientific discipline.
• Several years clinical or medical affairs experience in inflammation/immunology; MS therapeutic area experience.
• Value proposition knowledge.
• MS experience preferred.
• Good command of English.

About Us

COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE

At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.

"At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients."

There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin's lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.